Publication Name	World Journal of Diabetes
Manuscript ID	91845
Country	Greece

Received	2024-01-07 08:13
Peer-Review Started	2024-01-07 08:13
To Make the First Decision
Return for Revision	2024-01-20 07:08
Revised	2024-02-01 08:58
Second Decision	2024-03-25 01:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-03-25 05:30
Articles in Press	2024-03-25 05:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-26 11:05
Publish the Manuscript Online	2024-06-11 14:35

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	New perspectives in the management of diabetic nephropathy
Manuscript Source	Invited Manuscript
All Author List	Anna Psyllaki and Konstantinos Tziomalos
ORCID	Author(s) ORCID Number Konstantinos Tziomalos http://orcid.org/0000-0002-3172-1594
Funding Agency and Grant Number
Corresponding Author	Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, The First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomal@auth.gr
Key Words	Diabetes mellitus; Diabetic nephropathy; Sodium-glucose cotransporter 2 inhibitors; Finerenone; Glucagon-like peptide 1 receptor agonists; Finerenone
Core Tip	The management of diabetic nephropathy evolved substantially in recent years with the accumulation of evidence showing that sodium-glucose cotransporter 2 inhibitors and potentially finerenone prevent both renal function deterioration and cardiovascular events.
Publish Date	2024-06-11 14:35
Citation	<p>Psyllaki A, Tziomalos K. New perspectives in the management of diabetic nephropathy. <i>World J Diabetes</i> 2024; 15(6): 1086-1090</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i6/1086.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i6.1086

Full Article (PDF)	WJD-15-1086-with-cover.pdf
Manuscript File	91845_Auto_Edited-YJP.docx
Answering Reviewers	91845-answering-reviewers.pdf
Audio Core Tip	91845-audio.aac
Conflict-of-Interest Disclosure Form	91845-conflict-of-interest-statement.pdf
Copyright License Agreement	91845-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	91845-non-native-speakers.pdf
Peer-review Report	91845-peer-reviews.pdf
Scientific Misconduct Check	91845-scientific-misconduct-check.png
Scientific Editor Work List	91845-scientific-editor-work-list.pdf
CrossCheck Report	91845-crosscheck-report.pdf
CrossCheck Report	91845-crosscheck-report.png